Immunovant, Inc.
US ˙ NasdaqGS ˙ US45258J1025

SecurityIMVT / Immunovant, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership4,512 shares
Latest Disclosed Value $ 114,695
Group One Trading, L.p. ownership in IMVT / Immunovant, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 4,512 shares of Immunovant, Inc. (US:IMVT) valued at $114,695 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 9,041 shares of Immunovant, Inc.. This represents a change in shares of -50.09% during the quarter. The current value of the position is $147,407 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (IMVT) in the form of stock options. The firm currently holds call options representing 49,500 of underlying shares valued at $1,258,290 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IMVT / Immunovant, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F IMMUNOVANT COM 45258J102 4,512 -4,529 -50.09 115 -21.38 0.0002
2025-11-12 2025-09-30 13F IMMUNOVANT COM 45258J102 9,041 9,041 146 0.0003
2025-08-14 2025-06-30 13F IMMUNOVANT COM 45258J102 0 -24,771 -100.00 0 -100.00
2025-05-14 2025-03-31 13F IMMUNOVANT COM 45258J102 24,771 -59,937 -70.76 423 -79.84 0.0012
2025-05-14 2024-12-31 13F/A-1 IMMUNOVANT COM 45258J102 84,708 84,708 2,098 0.0048
2025-02-14 2024-12-31 13F IMMUNOVANT COM 45258J102 84,708 84,708 2,098 0.0052
2024-11-14 2024-09-30 13F IMMUNOVANT COM 45258J102 0 -59,007 -100.00 0 -100.00
2024-08-14 2024-06-30 13F IMMUNOVANT COM 45258J102 59,007 27,099 84.93 1,558 51.17 0.0060
2024-05-10 2024-03-31 13F IMMUNOVANT COM 45258J102 31,908 -105,599 -76.80 1,031 -82.22 0.0040
2024-02-14 2023-12-31 13F IMMUNOVANT COM 45258J102 137,507 137,507 5,793 0.0152
2023-11-09 2023-09-30 13F IMMUNOVANT COM 45258J102 0 -75,991 -100.00 0 -100.00
2023-08-09 2023-06-30 13F IMMUNOVANT COM 45258J102 75,991 52,135 218.54 1,442 289.46 0.0046
2023-05-12 2023-03-31 13F IMMUNOVANT COM 45258J102 23,856 23,856 370 0.0013
2023-02-09 2022-12-31 13F IMMUNOVANT COM 45258J102 0 -57,027 -100.00 0 -100.00
2022-11-09 2022-09-30 13F IMMUNOVANT COM 45258J102 57,027 -6,020 -9.55 318 29.27 0.0006
2022-08-11 2022-06-30 13F IMMUNOVANT COM 45258J102 63,047 5,937 10.40 246 -21.90 0.0004
2022-05-12 2022-03-31 13F IMMUNOVANT COM 45258J102 57,110 -27,184 -32.25 315 -56.13 0.0003
2022-02-11 2021-12-31 13F IMMUNOVANT COM 45258J102 84,294 4,482 5.62 718 3.46 0.0006
2021-11-12 2021-09-30 13F IMMUNOVANT COM 45258J102 79,812 48,544 155.25 694 109.67 0.0007
2021-08-10 2021-06-30 13F IMMUNOVANT COM 45258J102 31,268 21,642 224.83 331 114.94 0.0004
2021-05-12 2021-03-31 13F IMMUNOVANT COM 45258J102 9,626 9,626 154 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F IMMUNOVANT COM Call 49,500 -32.93 1,258 5.80 n/a n/a n/a
2025-11-12 2025-09-30 13F IMMUNOVANT COM Call 73,800 -5.38 1,190 -4.73 n/a n/a n/a
2025-08-14 2025-06-30 13F IMMUNOVANT COM Call 78,000 -81.49 1,248 -82.67 n/a n/a n/a
2025-05-14 2025-03-31 13F IMMUNOVANT COM Call 421,500 13.73 7,203 -21.53 n/a n/a n/a
2025-05-14 2024-12-31 13F/A IMMUNOVANT COM Call 370,600 2.49 9,180 -10.96 n/a n/a n/a
2025-02-14 2024-12-31 13F IMMUNOVANT COM Call 370,600 9,180 n/a n/a n/a
2024-11-14 2024-09-30 13F IMMUNOVANT COM Call 361,600 1,016.05 10,309 1,105.73 n/a n/a n/a
2024-08-14 2024-06-30 13F IMMUNOVANT COM Call 32,400 414.29 855 321.18 n/a n/a n/a
2024-05-10 2024-03-31 13F IMMUNOVANT COM Call 6,300 -94.71 204 -95.95 n/a n/a n/a
2024-02-14 2023-12-31 13F IMMUNOVANT COM Call 119,100 -78.92 5,018 -76.87 n/a n/a n/a
2023-11-09 2023-09-30 13F IMMUNOVANT COM Call 565,000 604.49 21,690 1,326.04 n/a n/a n/a
2023-08-09 2023-06-30 13F IMMUNOVANT COM Call 80,200 11.08 1,521 35.92 n/a n/a n/a
2023-05-12 2023-03-31 13F IMMUNOVANT COM Call 72,200 -49.15 1,120 -55.60 n/a n/a n/a
2023-02-09 2022-12-31 13F IMMUNOVANT COM Call 142,000 -29.32 2,520 124.80 n/a n/a n/a
2022-11-09 2022-09-30 13F IMMUNOVANT COM Call 200,900 -13.44 1,121 23.87 n/a n/a n/a
2022-08-11 2022-06-30 13F IMMUNOVANT COM Call 232,100 -62.28 905 -73.30 n/a n/a n/a
2022-05-12 2022-03-31 13F IMMUNOVANT COM Call 615,300 -53.49 3,390 -69.92 n/a n/a n/a
2022-02-11 2021-12-31 13F IMMUNOVANT COM Call 1,322,800 0.06 11,270 -1.90 n/a n/a n/a
2021-11-12 2021-09-30 13F IMMUNOVANT COM Call 1,322,000 73.49 11,488 42.64 n/a n/a n/a
2021-08-10 2021-06-30 13F IMMUNOVANT COM Call 762,000 6,827.27 8,054 4,476.14 n/a n/a n/a
2021-05-12 2021-03-31 13F IMMUNOVANT COM Call 11,000 176 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.